Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review
| Autor: | Albert C.M. Ong, Shoulian Zhou, Bo Yang, Cheng Xue, Jing Xu, Zhiguo Mao |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
kidney
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030232 urology & nephrology Review 030204 cardiovascular system & hematology Severe Acute Respiratory Syndrome Critical Care and Intensive Care Medicine medicine.disease_cause 03 medical and health sciences 0302 clinical medicine MERS Risk Factors Pandemic State of the Art Review Humans Medicine Pandemics Coronavirus SARS business.industry Incidence COVID-19 General Medicine Acute Kidney Injury Virology Diseases of the genitourinary system. Urology Renal Replacement Therapy Nephrology Meta-analysis outcome Kidney Failure Chronic RC870-923 Coronavirus Infections business |
| Zdroj: | Renal Failure article-version (VoR) Version of Record Renal Failure, Vol 43, Iss 1, Pp 1-15 (2021) |
| ISSN: | 1525-6049 0886-022X |
| DOI: | 10.1080/0886022x.2020.1847724 |
| Popis: | Objectives\ud \ud A meta-analysis and systematic review was conducted on kidney-related outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated with potentially fatal acute respiratory distress syndrome (ARDS).\ud \ud \ud Methods\ud \ud A search of all published studies until 16 June 2020 was performed. The incidence/prevalence and mortality risk of acute and chronic renal events were evaluated, virus prevalence, and mortality in preexisting hemodialysis patients was investigated.\ud \ud \ud Results\ud \ud A total of 58 eligible studies involving 13452 hospitalized patients with three types of coronavirus infection were included. The reported incidence of new-onset acute kidney injury (AKI) was 12.5% (95% CI: 7.6%–18.3%). AKI significantly increased the mortality risk (OR = 5.75, 95% CI 3.75–8.77, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|